Furthermore, our results demonstrated that EPDR1/TRPC1 inhibited the proliferation, migration, invasion, and interstitial-related protein expression of epirubicin-treated resistant BC cells by suppressing PI3K/AKT signaling pathway and increased the sensitivity of epirubicin-resistant BC cells. This evidence concerns the gene TRPC1 and breast cancer.